Skip to main content

ABVC BioPharma, Inc. (ABVC)

NASDAQ: ABVC · IEX Real-Time Price · USD
1.16
-0.09 (-7.20%)
At close: Dec 29, 2023, 4:00 PM
1.19
+0.03 (2.59%)
After-hours: Dec 29, 2023, 7:38 PM EST

ABVC BioPharma Revenue

ABVC BioPharma had revenue of $739.26K in the twelve months ending September 30, 2023, with 115.53% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $15.88K, a -62.42% decrease year-over-year. In the year 2022, ABVC BioPharma had annual revenue of $969.78K with 172.57% growth.

Revenue (ttm)
$739.26K
Revenue Growth
+115.53%
P/S Ratio
12.15
Revenue / Employee
$38,908
Employees
19
Market Cap
8.98M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022969.78K613.99K
172.57%
Dec 31, 2021355.80K-127.25K
-26.34%
Dec 31, 2020483.05K-218.67K
-31.16%
Dec 31, 2019701.72K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ABVC News

More News